Skip to main content
. Author manuscript; available in PMC: 2012 Jun 1.
Published in final edited form as: Ann Neurol. 2011 Mar 17;69(6):963–974. doi: 10.1002/ana.22354

Table 2.

Univariate Associations of Baseline Characteristics With Stroke in the Territory of the Symptomatic Stenotic Artery (n=287)

Characteristic HR (95% CI) P-value
Age (≥64 vs <64 yr) 0.58(0.31–1.08) 0.087
Sex (female vs male) 1.46(0.79–2.69) 0.225
Race (other vs white) 1.37(0.79–2.51) 0.310
Height (>67 vs ≤ 67 in) 1.03(0.55–1.92) 0.926
Weight (>180 vs ≤ 180 lbs) 0.83(0.45–1.54) 0.557
Body mass index (≥25 vs < 25 kg/m2) 1.67(0.74–3.77) 0.220
SBP (≥140 vs <140) 0.64(0.34–1.21) 0.170
DBP (≥80 vs < 80) 0.62(0.33–1.16) 0.133
LDL (≥100 vs < 100) 0.84(0.41–1.73) 0.645
HDL (<40 vs ≥ 40) 0.99(0.51–1.92) 0.966
Drinks alcohol (yes vs no) 1.01(0.55–1.88) 0.964
Ever smoked (yes vs no) 1.04(0.56–1.96) 0.893
Activity level (sedentary vs other) 0.91(0.45–1.85) 0.795
History of ischemic stroke (yes vs no) 1.32(0.66–2.63) 0.433
History of TIA (yes vs no) 0.68(0.31–1.46) 0.323
History of coronary arterial disease (yes vs no) 1.75(0.93–3.32) 0.084
History of hypertension (yes vs no) 1.25(0.49–3.18) 0.639
History of diabetes (yes vs no) 1.52(0.83–2.79) 0.172
History of lipid disease (yes vs no) 1.05(0.53–2.10) 0.888
NIH Stroke Scale score (>1 vs ≤ 1) 2.27(1.24–4.15) 0.008
Qualifying event (stroke vs TIA) 2.41(1.21–4.80) 0.013
Symptomatic vessel (posterior vs anterior) 1.00(0.55–1.84) 0.997
Percent stenosis (≥ 70% vs < 70%) 1.72(0.94–3.16) 0.079
On antithrombotic therapy at qualifying event (yes vs no) 1.03(0.56–1.90) 0.919
Time from qualifying event to enrollment (≤ 17 vs > 17 days) 1.70(0.91–3.15) 0.094
Treatment assignment (aspirin vs warfarin) 1.08(0.59–1.98) 0.797
Collaterals
     None vs. Good
     Poor vs. Good

1.14 (0.39–3.30)
4.36 (1.46–13.07)
0.0001